TPG GP A, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
TPG GP A, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$59,330,690
-36.2%
18,716,3060.0%1.02%
-25.0%
Q2 2023$93,020,041
+0.6%
18,716,3060.0%1.37%
-9.4%
Q1 2023$92,458,552
-21.5%
18,716,3060.0%1.51%
-34.8%
Q4 2022$117,725,565
-41.8%
18,716,3060.0%2.31%
-30.2%
Q3 2022$202,136,000
-5.3%
18,716,3060.0%3.31%
+0.4%
Q2 2022$213,366,000
+25.1%
18,716,3060.0%3.30%
+56.4%
Q1 2022$170,506,000
-38.9%
18,716,3060.0%2.11%
-24.4%
Q4 2021$279,247,00018,716,3062.79%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders